Post-earnings recap
Reported
Thu, Feb 23, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a loss per share of $0.21, which was below expectations. Despite this miss, the stock saw a slight increase of 0.72%, indicating that investors may have had lower expectations or are reacting positively to other factors not detailed in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.21 | N/A | -123.86% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.